• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

社论：在 COVID-19 大流行背景下，IBD（炎症性肠病）的患病率及其并发症不断增加。

Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic.

机构信息

Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.

Department of Medicine, University of Otago, Christchurch, New Zealand.

出版信息

Aliment Pharmacol Ther. 2020 Jun;51(12):1441-1442. doi: 10.1111/apt.15759. Epub 2020 May 14.

DOI:10.1111/apt.15759
PMID:32406119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7272894/
Abstract

This article is linked to King et al papers. To view these articles, visit https://doi.org/10.1111/apt.15701 and https://doi.org/10.1111/apt.15769.

摘要

本文与 King 等人的论文有关。欲查看这些文章，请访问 https://doi.org/10.1111/apt.15701 和 https://doi.org/10.1111/apt.15769。

相似文献

1
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic.社论：在 COVID-19 大流行背景下，IBD（炎症性肠病）的患病率及其并发症不断增加。
Aliment Pharmacol Ther. 2020 Jun;51(12):1441-1442. doi: 10.1111/apt.15759. Epub 2020 May 14.
2
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.社论：在 COVID-19 大流行背景下，IBD 的患病率及其并发症不断增加。作者回复。
Aliment Pharmacol Ther. 2020 Jun;51(12):1442-1443. doi: 10.1111/apt.15769. Epub 2020 May 14.
3
Editorial: social distancing during the COVID-19 pandemic - IBD patients cannot stay at home forever.社论：2019冠状病毒病大流行期间的社交距离——炎症性肠病患者不能永远居家
Aliment Pharmacol Ther. 2020 Aug;52(4):717-718. doi: 10.1111/apt.15874.
4
Editorial: social distancing during the COVID-19 pandemic-IBD patients cannot stay at home forever. Authors' reply.社论：2019冠状病毒病大流行期间的社交距离——炎症性肠病患者不能永远居家。作者回复。
Aliment Pharmacol Ther. 2020 Aug;52(4):719-720. doi: 10.1111/apt.15937.
5
Protecting patients with IBD during the COVID-19 pandemic.在新冠疫情期间保护炎症性肠病患者。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):639. doi: 10.1016/S2468-1253(20)30152-7. Epub 2020 May 20.
6
IBD in the Times of COVID-19.新冠疫情时代的炎症性肠病
Inflamm Bowel Dis. 2020 Jul 17;26(8):e92. doi: 10.1093/ibd/izaa132.
7
Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.在新冠疫情期间管理炎症性肠病输液单元：服务调整与患者视角
Inflamm Bowel Dis. 2020 Sep 18;26(10):e125-e126. doi: 10.1093/ibd/izaa171.
8
Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic.2019冠状病毒病大流行期间不愿或无法接受输液治疗的炎症性肠病患者的管理
Inflamm Bowel Dis. 2020 Oct 23;26(11):e137. doi: 10.1093/ibd/izaa207.
9
Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak.雾化吸入在炎症性肠病管理中的应用：新冠疫情期间炎症性肠病发作的一个罕见病例
Inflamm Bowel Dis. 2020 Sep 18;26(10):e128-e129. doi: 10.1093/ibd/izaa184.
10
Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis.致编辑的信的回复：炎症性肠病患者中新冠病毒病的发病率和结局：快速综述与荟萃分析
Inflamm Bowel Dis. 2020 Sep 18;26(10):e127. doi: 10.1093/ibd/izaa172.

引用本文的文献

1
Causal relationship between atherosclerosis and inflammatory bowel disease risk: a two-sample Mendelian randomization study.动脉粥样硬化与炎症性肠病风险之间的因果关系：一项两样本孟德尔随机化研究。
Thromb J. 2025 Apr 23;23(1):39. doi: 10.1186/s12959-025-00722-y.
2
Robust reactive oxygen species modulator hitchhiking yeast microcapsules for colitis alleviation by trilogically intestinal microenvironment renovation.用于通过三重肠道微环境修复缓解结肠炎的稳健活性氧调节剂搭载酵母微胶囊
Bioact Mater. 2024 Mar 5;36:203-220. doi: 10.1016/j.bioactmat.2024.02.033. eCollection 2024 Jun.
3
What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials.我们对炎症性肠病、多发性硬化症和类风湿性关节炎的药物依从性干预措施了解多少？一项随机对照试验的范围综述
Patient Prefer Adherence. 2023 Dec 13;17:3265-3303. doi: 10.2147/PPA.S424024. eCollection 2023.
4
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.社论：在 COVID-19 大流行背景下，IBD 的患病率及其并发症不断增加。作者回复。
Aliment Pharmacol Ther. 2020 Jun;51(12):1442-1443. doi: 10.1111/apt.15769. Epub 2020 May 14.

本文引用的文献

1
Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018.英国炎症性肠病的流行病学和结局变化模式：2000-2018 年。
Aliment Pharmacol Ther. 2020 May;51(10):922-934. doi: 10.1111/apt.15701. Epub 2020 Apr 1.
2
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience.COVID-19 大流行时代的炎症性肠病护理：米兰 Humanitas 大学的经验。
J Crohns Colitis. 2020 Sep 16;14(9):1330-1333. doi: 10.1093/ecco-jcc/jjaa058.
3
Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease.系统评价与荟萃分析：生物制剂在老年炎症性肠病患者中的感染或癌症风险。
Aliment Pharmacol Ther. 2020 May;51(9):820-830. doi: 10.1111/apt.15692. Epub 2020 Mar 13.
4
Risk of colorectal cancer in inflammatory bowel diseases.炎症性肠病相关结直肠癌的发病风险。
Semin Cancer Biol. 2020 Aug;64:51-60. doi: 10.1016/j.semcancer.2019.05.001. Epub 2019 May 18.
5
The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23-year period: a population-based study.丹麦和芬兰 23 年间儿科发病炎症性肠病的癌症发病率和死亡率：一项基于人群的研究。
Aliment Pharmacol Ther. 2019 Jul;50(1):33-39. doi: 10.1111/apt.15258. Epub 2019 May 8.
6
The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity.炎症性肠病活动期患者住院期间和出院后的静脉血栓栓塞风险。
Aliment Pharmacol Ther. 2018 Nov;48(10):1099-1108. doi: 10.1111/apt.15010. Epub 2018 Oct 8.
7
Predictors for developing intestinal failure in patients with Crohn's disease.克罗恩病患者发生肠衰竭的预测因素。
J Gastroenterol Hepatol. 2013 May;28(5):801-7. doi: 10.1111/jgh.12115.